Abbott Laboratories raised its full-year earnings forecast and topped estimates for quarterly profit on Wednesday, powered by demand for its glucose monitoring device for diabetics and gains from its multibillion dollar acquisitions.
from Reuters: Health https://ift.tt/2uHgQcv
via IFTTT
0 comments: